Related Experiment Video

Updated: May 18, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Suppression of cancer progression by MGAT1 shRNA knockdown

Reza Beheshti Zavareh1, Mahadeo A Sukhai, Rose Hurren

  • 1Ontario Cancer Institute, Princess Margaret Hospital, and Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.

Plos One
|September 8, 2012
PubMed

Insights

Blocking N-acetylglucosaminyltransferase I (MGAT1) reduces tumor invasion and metastasis by decreasing branched N-glycans. This study highlights MGAT1 as a potential therapeutic target for cancer treatment.

Area of Science:

  • Glycobiology
  • Cancer Biology
  • Molecular Oncology

Background:

  • Oncogenic signaling elevates branched N-glycans, promoting tumor invasion and metastasis.
  • Branched N-glycans facilitate cell surface receptor interactions and focal adhesion dynamics.
  • N-acetylglucosaminyltransferase I (MGAT1) is crucial for initiating N-glycan branching.

Purpose of the Study:

  • To investigate the role of MGAT1 in tumor cell migration, invasion, and metastasis.
  • To evaluate MGAT1 as a potential therapeutic target for cancer treatment.

Main Methods:

  • MGAT1 knockdown using shRNA in human cervical (HeLa) and prostate (PC-3-Yellow) cancer cell lines.
  • Assessment of N-glycan expression, enzyme activity, cell migration, invasion, and proliferation.
  • In vivo studies using prostate cancer xenografts to evaluate tumor growth and metastasis.

Main Results:

  • MGAT1 knockdown reduced cell surface branched N-glycans, inhibited HeLa cell migration and invasion, but did not affect proliferation.
  • Swainsonine, an inhibitor downstream of MGAT1, showed similar effects on invasion, suggesting a common pathway.
  • MGAT1 knockdown in vivo decreased primary tumor growth and lung metastasis incidence in PC-3-Yellow xenografts.

Conclusions:

  • MGAT1 is essential for promoting cancer cell migration, invasion, and metastasis.
  • Targeting MGAT1 represents a promising therapeutic strategy for inhibiting cancer progression and metastasis.

More Related Videos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...